aldosterone has been researched along with Cerebrovascular Disorders in 31 studies
Cerebrovascular Disorders: A spectrum of pathological conditions of impaired blood flow in the brain. They can involve vessels (ARTERIES or VEINS) in the CEREBRUM, the CEREBELLUM, and the BRAIN STEM. Major categories include INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; and others.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Allisartan isoproxil (ALL) is a new angiotensin II receptor blocker and a new antihypertensive drug discovered and developed in China." | 5.62 | Allisartan isoproxil reduces mortality of stroke-prone rats and protects against cerebrovascular, cardiac, and aortic damage. ( Cheng, MH; Fu, FH; Ling, QS; Liu, AJ; Liu, JG; Miao, CY; Tian, JS; Zhang, SL, 2021) |
| " We measured the urinary excretion of 19-noraldosterone in the spontaneously hypertensive rat (SHR) and stroke-prone SHR (SHRSP) during the development of hypertension and compared these measurements with Wistar-Kyoto (WKY) rats." | 3.69 | Urinary excretion of 19-noraldosterone in the spontaneously hypertensive rat and stroke-prone spontaneously hypertensive rat. ( Hurukawa, K; Inaba, S; Ito, Y; Miyamori, I; Takeda, R; Takeda, Y; Yoneda, T, 1995) |
| "Elevations in plasma aldosterone enhance stroke development within captopril-treated SHRSP through mechanisms that do not involve stimulation of mineralocorticoid receptors or the enhancement of hypertension." | 3.69 | The role of blood pressure and aldosterone in the production of hemorrhagic stroke in captopril-treated hypertensive rats. ( MacLeod, AB; Smeda, JS; Vasdev, S, 1997) |
| "Aldosterone is a mineralocorticoid hormone that participates in the regulation of electrolyte balance, blood pressure, and tissue remodeling." | 2.61 | Endothelial Dysfunction in Primary Aldosteronism. ( Chen, ZW; Chou, CH; Hung, CS; Liao, CW; Lin, YH; Pan, CT; Tsai, CH; Wu, VC, 2019) |
| "Moreover, primary aldosteronism patients are exposed to an increased risk of cardio and cerebrovascular events and metabolic comorbidities compared with patients affected by essential hypertension." | 2.58 | Primary aldosteronism in the primary care setting. ( Buffolo, F; Monticone, S; Mulatero, P; Tetti, M, 2018) |
| "Aldosterone has also been demonstrated to be a major factor in target organ damage independent of its effects on blood pressure." | 2.44 | Aldosterone as an independent factor in cerebrovascular damage. ( Bertello, C; Caserta, M; Giraudo, G; Morello, F; Mulatero, P; Schiavone, D; Veglio, F; Verhovez, A, 2008) |
| "Allisartan isoproxil (ALL) is a new angiotensin II receptor blocker and a new antihypertensive drug discovered and developed in China." | 1.62 | Allisartan isoproxil reduces mortality of stroke-prone rats and protects against cerebrovascular, cardiac, and aortic damage. ( Cheng, MH; Fu, FH; Ling, QS; Liu, AJ; Liu, JG; Miao, CY; Tian, JS; Zhang, SL, 2021) |
| "Mean aldosterone levels were highest in the TT group and lowest in CC group (p = 0." | 1.48 | Modulation of aldosterone levels by aldosterone synthase promoter polymorphism and association with eGFR decline in patients with chronic kidney disease. ( Gu, Y; Hao, C; Lai, L; Qian, J; Shi, H; Yan, M; Zhong, J, 2018) |
| "Both fibrinogen and PAI-1 were independent predictors of the presence of organ damage and their inclusion in a multivariate model eliminated PRA and aldosterone as independent predictors." | 1.35 | Relationship of plasma renin with a prothrombotic state in hypertension: relevance for organ damage. ( Casanova-Borca, A; Catena, C; Chiuch, A; Colussi, G; Di Fabio, A; Nadalini, E; Novello, M; Sechi, LA; Uzzau, A, 2008) |
| "Special treatment for hyponatremia was not given in 30 of the 58 cases (control group)." | 1.28 | [Mechanism and therapy of hyponatremia with central origin]. ( Morinaga, K; Ohkawara, S; Tabuse, H, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (38.71) | 18.7374 |
| 1990's | 10 (32.26) | 18.2507 |
| 2000's | 3 (9.68) | 29.6817 |
| 2010's | 5 (16.13) | 24.3611 |
| 2020's | 1 (3.23) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, ZW | 1 |
| Tsai, CH | 1 |
| Pan, CT | 1 |
| Chou, CH | 1 |
| Liao, CW | 1 |
| Hung, CS | 1 |
| Wu, VC | 1 |
| Lin, YH | 1 |
| Ling, QS | 1 |
| Zhang, SL | 1 |
| Tian, JS | 1 |
| Cheng, MH | 1 |
| Liu, AJ | 1 |
| Fu, FH | 1 |
| Liu, JG | 1 |
| Miao, CY | 1 |
| Buffolo, F | 1 |
| Monticone, S | 1 |
| Tetti, M | 1 |
| Mulatero, P | 2 |
| Qian, J | 1 |
| Zhong, J | 1 |
| Yan, M | 1 |
| Shi, H | 1 |
| Hao, C | 1 |
| Gu, Y | 1 |
| Lai, L | 1 |
| Lu, ZH | 1 |
| Zhu, XX | 1 |
| Tang, ZQ | 1 |
| Yang, GQ | 1 |
| Du, J | 1 |
| Wang, XL | 1 |
| Yang, JZ | 1 |
| Gu, WJ | 1 |
| Guo, QH | 1 |
| Jin, N | 1 |
| Yang, LJ | 1 |
| Ba, JM | 1 |
| Dou, JT | 1 |
| Mu, YM | 1 |
| Dézsi, CA | 1 |
| Sechi, LA | 1 |
| Novello, M | 1 |
| Colussi, G | 1 |
| Di Fabio, A | 1 |
| Chiuch, A | 1 |
| Nadalini, E | 1 |
| Casanova-Borca, A | 1 |
| Uzzau, A | 1 |
| Catena, C | 1 |
| Caserta, M | 1 |
| Bertello, C | 1 |
| Schiavone, D | 1 |
| Verhovez, A | 1 |
| Giraudo, G | 1 |
| Morello, F | 1 |
| Veglio, F | 1 |
| Skvortsova, VI | 1 |
| Platonova, IA | 1 |
| Tvorogova, TV | 1 |
| Volkovenko, OV | 1 |
| Demidova, LI | 1 |
| Ostrovtsev, IV | 1 |
| Unger, T | 1 |
| Yukimura, T | 1 |
| Marin-Grez, M | 1 |
| Lang, RE | 1 |
| Rascher, W | 1 |
| Ganten, D | 2 |
| Stasiński, T | 1 |
| Lehmann, Z | 1 |
| Kostka-Wach, M | 1 |
| Biryńczyk, J | 1 |
| Warenik-Szymankiewicz, A | 1 |
| Laragh, JH | 2 |
| Volpe, M | 3 |
| Rubattu, S | 2 |
| Enea, I | 1 |
| Russo, R | 1 |
| Lembo, G | 3 |
| Mirante, A | 1 |
| Condorelli, G | 2 |
| Trimarco, B | 2 |
| Graf, C | 1 |
| Maser-Gluth, C | 1 |
| de Muinck Keizer, W | 1 |
| Rettig, R | 1 |
| Takeda, Y | 1 |
| Miyamori, I | 1 |
| Yoneda, T | 1 |
| Hurukawa, K | 1 |
| Inaba, S | 1 |
| Ito, Y | 1 |
| Takeda, R | 1 |
| MacLeod, AB | 1 |
| Vasdev, S | 1 |
| Smeda, JS | 1 |
| Stasch, JP | 1 |
| Knorr, A | 1 |
| Hirth-Dietrich, C | 1 |
| Krämer, T | 1 |
| Hübsch, W | 1 |
| Dressel, J | 1 |
| Fey, P | 1 |
| Beuck, M | 1 |
| Sander, E | 1 |
| Frobel, K | 1 |
| Kazda, S | 1 |
| Amery, A | 1 |
| Wasir, H | 1 |
| Bulpitt, C | 1 |
| Conway, J | 1 |
| Fagard, R | 1 |
| Lijnen, P | 1 |
| Reybrouck, T | 1 |
| Zweifler, AJ | 1 |
| Esler, M | 1 |
| Omae, T | 1 |
| Perez-Stable, EC | 1 |
| Materson, BJ | 1 |
| Kim, S | 2 |
| Tokuyama, M | 1 |
| Hosoi, M | 2 |
| Yamamoto, K | 2 |
| De Luca, N | 1 |
| Lamenza, F | 1 |
| Tritto, C | 2 |
| Ricciardelli, B | 1 |
| Molaro, M | 1 |
| De Campora, P | 1 |
| Rendina, V | 1 |
| Mele, AF | 1 |
| deCampora, P | 1 |
| Condorelli, M | 1 |
| Shimamoto, K | 1 |
| Takada, T | 1 |
| Morinaga, K | 2 |
| Matsuoka, T | 1 |
| Matsumoto, Y | 1 |
| Ohmiya, N | 1 |
| Mikami, J | 1 |
| Ueda, M | 1 |
| Sato, H | 1 |
| Takahashi, Y | 1 |
| Inoue, Y | 1 |
| Takeda, S | 1 |
| Tabuse, H | 1 |
| Ohkawara, S | 1 |
| Fedirko, MI | 1 |
| Ershova, GS | 1 |
| Brunner, HR | 1 |
| Baer, L | 1 |
| Newton, MA | 1 |
| Goodwin, FT | 1 |
| Krakoff, LR | 1 |
| Bard, RH | 1 |
| Bühler, FR | 1 |
| Wood, JE | 1 |
| Kloppenborg, PW | 1 |
| Drayer, JI | 1 |
| Van Haelst, AJ | 1 |
| Benraad, HB | 1 |
| Van't Laar, A | 1 |
| Smals, AG | 1 |
| Benraad, TJ | 1 |
8 reviews available for aldosterone and Cerebrovascular Disorders
| Article | Year |
|---|---|
Endothelial Dysfunction in Primary Aldosteronism.
Topics: Aldosterone; Cardiovascular Diseases; Cerebrovascular Disorders; Disease Progression; Humans; Hypera | 2019 |
Primary aldosteronism in the primary care setting.
Topics: Adrenalectomy; Aldosterone; Blood Pressure; Cardiovascular Diseases; Cerebrovascular Disorders; Huma | 2018 |
The Different Therapeutic Choices with ARBs. Which One to Give? When? Why?
Topics: Aldosterone; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Blood Pressu | 2016 |
Aldosterone as an independent factor in cerebrovascular damage.
Topics: Aldosterone; Animals; Blood Pressure; Cerebrovascular Disorders; Disease Models, Animal; Humans; Hyp | 2008 |
[Effect of oral contraceptives on the circulatory system].
Topics: Aldosterone; Angiotensin II; Cardiovascular Diseases; Cerebrovascular Disorders; Contraceptives, Ora | 1980 |
Renin-angiotensin-aldosterone system for blood pressure and electrolyte homeostasis and its involvement in hypertension, in congestive heart failure and in associated cardiovascular damage (myocardial infarction and stroke).
Topics: Aldosterone; Animals; Blood Pressure; Cardiovascular Diseases; Cerebrovascular Disorders; Electrolyt | 1995 |
Aging and the cardiovascular system.
Topics: Aged; Aging; Aldosterone; Angiotensin II; Antihypertensive Agents; Blood Pressure; Cardiac Output; C | 1978 |
The cardiovascular effects of oral contraceptives.
Topics: Aldosterone; Angiotensin II; Blood Coagulation; Blood Flow Velocity; Blood Vessels; Cardiovascular S | 1972 |
23 other studies available for aldosterone and Cerebrovascular Disorders
| Article | Year |
|---|---|
Allisartan isoproxil reduces mortality of stroke-prone rats and protects against cerebrovascular, cardiac, and aortic damage.
Topics: Aldosterone; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Aorta; Aorti | 2021 |
Modulation of aldosterone levels by aldosterone synthase promoter polymorphism and association with eGFR decline in patients with chronic kidney disease.
Topics: Adult; Aged; Aldosterone; Cardiovascular Diseases; Cerebrovascular Disorders; Cytochrome P-450 CYP11 | 2018 |
Female sex hormones are associated with the reduction of serum sodium and hypertension complications in patients with aldosterone-producing adenoma.
Topics: Adenoma; Adrenal Gland Neoplasms; Adrenalectomy; Aldosterone; Biomarkers; Cerebrovascular Disorders; | 2013 |
Relationship of plasma renin with a prothrombotic state in hypertension: relevance for organ damage.
Topics: Adult; Aldosterone; Algorithms; Analysis of Variance; Biomarkers; Cerebrovascular Disorders; Cross-S | 2008 |
[The influence of the hormones of hypothalamo-pituitary-adrenal, renin-angiotensin, and thyroid hormonal systems on formation of vascular encephalopathy].
Topics: Adrenocorticotropic Hormone; Aged; Aldosterone; Analysis of Variance; Cerebrovascular Circulation; C | 2003 |
SA446, a new orally active converting enzyme inhibitor: antihypertensive action and comparison with captopril in stroke-prone spontaneously hypersensitive rats.
Topics: 3-Mercaptopropionic Acid; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypert | 1982 |
Dietary salt excess unmasks blunted aldosterone suppression and sodium retention in the stroke-prone phenotype of the spontaneously hypertensive rat.
Topics: Administration, Oral; Aldosterone; Animals; Blood Pressure; Body Weight; Cerebrovascular Disorders; | 1993 |
Sodium retention and hypertension after kidney transplantation in rats.
Topics: Aldosterone; Animals; Blood Pressure; Body Weight; Cerebrovascular Disorders; Diet; Hypertension; Ki | 1993 |
Urinary excretion of 19-noraldosterone in the spontaneously hypertensive rat and stroke-prone spontaneously hypertensive rat.
Topics: Aldosterone; Animals; Cerebrovascular Disorders; Chromatography, High Pressure Liquid; Hypertension; | 1995 |
The role of blood pressure and aldosterone in the production of hemorrhagic stroke in captopril-treated hypertensive rats.
Topics: Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; Cerebral | 1997 |
Long-term blockade of the angiotensin II receptor in renin transgenic rats, salt-loaded Dahl rats, and stroke-prone spontaneously hypertensive rats.
Topics: Aldosterone; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Animals, Genetically Modifie | 1997 |
Factors influencing the choice of antihypertensive agents.
Topics: Age Factors; Aldosterone; Cerebrovascular Disorders; Clonidine; Depression; Diabetes Complications; | 1976 |
[Disturbances of autoregulation in stroke. (2) The Renin-angiotensin-aldosterone system].
Topics: Adult; Aged; Aldosterone; Angiotensin II; Animals; Cerebrovascular Disorders; Humans; Male; Middle A | 1976 |
Workup of the newly discovered hypertensive patient.
Topics: Adult; Aldosterone; Angiotensin II; Cardiac Output; Cerebrovascular Disorders; Contraceptives, Oral; | 1975 |
Adrenal and circulating renin-angiotensin system in stroke-prone hypertensive rats.
Topics: Adrenal Glands; Aldosterone; Angiotensin II; Animals; Cerebrovascular Disorders; Concanavalin A; Enz | 1992 |
Abnormal hormonal and renal responses to saline load in hypertensive patients with parental history of cardiovascular accidents.
Topics: Adult; Aldosterone; Atrial Natriuretic Factor; Blood Pressure; Cerebrovascular Disorders; Family Hea | 1991 |
Impairment of atrial natriuretic factor response to acute saline load in hypertensives with family history of cardiovascular accidents.
Topics: Adult; Aldosterone; Atrial Natriuretic Factor; Cerebrovascular Disorders; Female; Humans; Hypertensi | 1991 |
Increased production of angiotensin II in the adrenal gland of stroke-prone spontaneously hypertensive rats with malignant hypertension.
Topics: Adrenal Glands; Aging; Aldosterone; Angiotensin I; Angiotensin II; Animals; Cerebrovascular Disorder | 1991 |
[Mechanism of hyponatremia in the acute phase of cerebrovascular diseases].
Topics: Adult; Aged; Aldosterone; Blood Urea Nitrogen; Cerebrovascular Disorders; Humans; Hyponatremia; Midd | 1987 |
[Mechanism and therapy of hyponatremia with central origin].
Topics: Aldosterone; Cerebrovascular Disorders; Craniocerebral Trauma; Glucose; Humans; Hydrocortisone; Hypo | 1989 |
[Renin-angiotensin-aldosterone system in hypertension patients who have had a cerebral stroke].
Topics: Aged; Aldosterone; Cerebrovascular Disorders; Chronic Disease; Humans; Hypertension; Middle Aged; Re | 1987 |
Essential hypertension: renin and aldosterone, heart attack and stroke.
Topics: Adult; Aldosterone; Cardiomegaly; Cerebrovascular Disorders; Female; Humans; Hypertension; Male; Mid | 1972 |
Primary aldosteronism, idiopathic aldosteronism and "low-renin" benign essential hypertension. A retrospective study.
Topics: Adult; Age Factors; Aged; Aldosterone; Blood Pressure; Cerebrovascular Disorders; Female; Humans; Hy | 1974 |